Jong Joseph Kim, Chief Executive Officer, 10% Owner at INOVIO PHARMACEUTICALS, INC. (INO), bought 15,000 shares at $0.41 ($6K) on 2012-06-13, disclosed to the SEC on 2012-06-13.
Open-market purchase of $6k INO by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| INO | BUY | 2020-01-13 | $70K | — | Filing → |
| INO | SELL | 2019-06-04 | $7.6M | — | Filing → |
| INO | SELL | 2019-05-23 | $331K | — | Filing → |